Outpatient Opioid and Naloxone Prescribing Practices at an Academic Medical Center during the COVID-19 Pandemic

被引:2
|
作者
Torres, Erica L. [1 ]
Evoy, Kirk E. [1 ,2 ]
Thomas, Lindsay O. [1 ,3 ]
机构
[1] Univ Health, Dept Pharmacotherapy & Pharm Serv, San Antonio, TX USA
[2] Univ Texas Austin, Coll Pharm, Pharmacotherapy Div, Austin, TX 78712 USA
[3] Univ Incarnate Word, Feik Sch Pharm, Dept Pharm Practice, San Antonio, TX USA
关键词
Opioid; naloxone; outpatient; opioid prescribing; COVID-19; UNITED-STATES; PRESCRIPTIONS; TRENDS; DRUG;
D O I
10.1080/15360288.2022.2105471
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
While improving opioid safety has been a national priority, the coronavirus disease 2019 (COVID-19) pandemic has been associated with increased rates of opioid overdose. The present study characterized outpatient opioid and naloxone prescribing patterns during the COVID-19 pandemic. A retrospective chart review was conducted of adult patients receiving opioid therapy between August 2020 through October 2020 from outpatient clinics within a Texas health system. The primary outcome was naloxone co-prescription during the study period or within the year prior. During the study period, 1,368 patients received an opioid prescription, most of which were prescribed for chronic pain treatment (63.0%). Most opioid prescriptions (91.5%) were written for < 50 MME/day. For prescriptions written for acute pain, 78% were written for <= 10 days supply. While 31.1% of patients received gabapentinoid prescriptions, few (7.9%) received benzodiazepine or Z-hypnotic prescriptions. Twenty-two (1.6%) patients were co-prescribed naloxone. In this study, naloxone was rarely prescribed for outpatients receiving opioid prescriptions during the COVID-19 pandemic. Health systems should continue to prioritize adherence to evidence-based clinical guidelines and increase access to naloxone.
引用
收藏
页码:178 / 186
页数:9
相关论文
共 50 条
  • [41] COVID-19 pandemic and impact on cancer clinical trials: An academic medical center perspective
    Marcum, Michelle
    Kurtzweil, Nicky
    Vollmer, Christine
    Schmid, Lisa
    Vollmer, Ashley
    Kastl, Alison
    Acker, Kelly
    Gulati, Shuchi
    Grover, Punita
    Herzog, Thomas J.
    Ahmad, Syed A.
    Sohal, Davendra
    Wise-Draper, Trisha M.
    CANCER MEDICINE, 2020, 9 (17): : 6141 - 6146
  • [42] COVID-19 Pandemic and Telehealth: allergy patient perspectives in an urban, academic medical center
    Patel, Darshil
    Pappalardo, Andrea
    Harmon, Vanessa
    Pasquinelli, Mary
    Trosman, Julia
    Weldon, Christine
    Nyenhuis, Sharmilee
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB168 - AB168
  • [43] Telemedicine Utilization at an Academic Medical Center During COVID-19 Pandemic: Are Some Patients Being Left Behind?
    Lott, Ariana
    Campbell, Kirk A.
    Hutzler, Lorraine
    Lajam, Claudette M.
    TELEMEDICINE AND E-HEALTH, 2022, 28 (01) : 44 - 50
  • [44] Broadband internet subscription rates and opioid prescribing via telemedicine during the COVID-19 pandemic
    Oyler, Douglas R.
    Slavova, Svetla
    Freeman, Patricia R.
    Huang, Zhengyan
    Talbert, Jeffery
    Walsh, Sharon L.
    Westgate, Philip M.
    JOURNAL OF RURAL HEALTH, 2022, 38 (04): : 900 - 907
  • [45] Early Changes to Neurosurgery Resident Training During the COVID-19 Pandemic at a Large US Academic Medical Center
    Burks, Joshua D.
    Luther, Evan M.
    Govindarajan, Vaidya
    Shah, Ashish H.
    Levi, Allan D.
    Komotar, Ricardo J.
    WORLD NEUROSURGERY, 2020, 144 : E926 - E933
  • [46] TRANSFORMATIVE LEARNING DURING THE COVID-19 PANDEMIC: A CROSS-SECTIONAL SURVEY OF TRAINEES AT AN ACADEMIC MEDICAL CENTER
    Vipler, Benjamin
    Snyder, Bethany
    McCall-Hosenfeld, Jennifer
    Haidet, Paul
    Peyrot, Mark
    Stuckey, Heather
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (SUPPL 1) : S114 - S114
  • [47] MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE CLINIC DURING THE COVID-19 PANDEMIC: CARING FOR THE VULNERABLE IN AN ACADEMIC MEDICAL CENTER
    Lee, Holly
    Tay, Jason
    Street, Lesley
    Duggan, Peter
    Jimenez-Zepeda, Victor H.
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2021, 73 (04): : 259 - 264
  • [48] Gender differences in isotretinoin prescriptions during the COVID-19 pandemic at a U.S. academic medical center
    Grace Y. Duan
    Arlene M. Ruiz de Luzuriaga
    Archives of Dermatological Research, 2023, 315 : 643 - 645
  • [49] Opioid prescribing in the Netherlands during the COVID-19 pandemic: a national register-based study
    Ellerbroek, Hannah
    Schellekens, Arnt F. A.
    Kalkman, Gerard A.
    Visser, Damian A.
    Kramers, Cornelis
    Dahan, Albert
    van den Heuvel, Sandra A. S.
    Bouvy, Marcel L.
    van Dorp, Eveline L. A.
    BMJ OPEN, 2024, 14 (08):
  • [50] Changes in opioid prescribing on veterans with headache during the COVID-19 pandemic: A regression discontinuity analysis
    Wang, K.
    HEADACHE, 2022, 62 (07): : 915 - 916